Dental Care Clinics in Chanute, KS Accepting Medicare
3 Dental Care Clinics found. Showing 1 - 3
 Kenneth L Williams D.d.s. P.a. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2607 S Santa Fe Ave, Chanute, KS 66720 Phone: 620-431-3000 Fax: 620-431-6122 |
David M Jones, Dds Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 32 W Main, Chanute, KS 66720 Phone: 562-043-1482 Fax: 620-431-6959 |
Grant Gastineau, Dds, Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 32 W Main St, Chanute, KS 66720 Phone: 620-431-4823 |
News Archive
Millions of children in developing world have no access to clean water, latrines at school, report finds
A report, released this week by UNICEF during the Dubai International Humanitarian Aid & Development conference, documents the challenges many schoolchildren in developing countries face in accessing safe drinking water and sanitation, United Press International reports (4/6).
Citric acid in e-liquids may produce significant amounts of respiratory sensitisers in e-cigarette vapour
The use of citric acid in e-liquids needs to be investigated to further understand its potential to form potentially harmful anhydrides in the vapour.
Growth in demand for Noveko International's antimicrobial products
Noveko International Inc. ("the Company") is pleased to announce that the value of its firm orders for its Noveko(TM) antimicrobial face masks and respirators and AZURO(TM) hand sanitizers, for the period beginning July 1st, 2009, currently totals approximately $18 million, i.e. $12 million for face masks and respirators and $6 million for sanitizers. This significant number of orders reflects the sharp increase in demand for the Company's antimicrobial products. The orders come mainly from various distributors, notably Eval Consulting, BLD Distribution L.L.C., Aerosys Technologies and Medi-Select.
Updated clinical data from phase I study of Ensituximab presented at AACR meeting
Precision Biologics announced today that in conjunction with researchers from Precsion Biologics , Johns Hopkins Medical Center and Duke University Medical Center presented updated clinical data from the phase I study of Ensituximab, a novel therapeutic antibody to treat pancreas and colorectal cancers
› Verified 1 days ago